Similarly, the back-splicing of the non-small cell lung cancer (NSCLC)-associated EML4-ALK fusion variant 3b generates a tumor-promoting circRNA named f-circEA [83] and an additional variant (f-circEA-2a) which enhances cell migration and invasion [85]. Here, ALK is linked to non-small cell lung carcinoma.